BIOMAT Database Logo BIOMAT Database Logo

[The treatment of tetanus by intrathecal heterologous antitetanus serum]. 1978

I D Mar, and S Badiane, and A Ba

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

I D Mar, and S Badiane, and A Ba
Intrathecal antitetanus serum (horse) in the treatment of tetanus.
May 1977, Lancet (London, England),
I D Mar, and S Badiane, and A Ba
Intrathecal antitetanus serum in the management of tetanus.
January 1982, East African medical journal,
I D Mar, and S Badiane, and A Ba
Intrathecal antitetanus serum (horse) with steroid in the treatment of neonatal tetanus.
July 1980, Archives of disease in childhood,
I D Mar, and S Badiane, and A Ba
[Treatment of tetanus by small doses of antitetanus serum].
August 1969, Vrachebnoe delo,
I D Mar, and S Badiane, and A Ba
Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus.
April 1983, Archives of disease in childhood,
I D Mar, and S Badiane, and A Ba
[The value of intrathecal administration of antitetanus serum and corticoids in the treatment of manifest tetanus].
April 1977, La Nouvelle presse medicale,
I D Mar, and S Badiane, and A Ba
Human Antitetanus Serum in the Treatment of Tetanus.
April 1963, British medical journal,
I D Mar, and S Badiane, and A Ba
Dosage of antitetanus serum in the treatment of tetanus.
October 1960, Indian journal of medical sciences,
I D Mar, and S Badiane, and A Ba
Dosage of antitetanus serum in the treatment of tetanus.
June 1958, Indian journal of medical sciences,
I D Mar, and S Badiane, and A Ba
Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route.
March 2004, BMJ (Clinical research ed.),
Copied contents to your clipboard!